Skip to main content

Pfizer Will Fight to Retain Celebrex Patent Protection

Pharmaceutical firm said it will appeal federal court's refusal to extend patent protection for its blockbuster drug. read more
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.